Microbiology & Diagnostics

Diagnostic Solutions ǀ Healthcare Challenges

Bruker’s diagnostic solutions meet today’s healthcare challenges

Healthcare challenges

Species level identification of microorganisms is vital in combating the vast range of pathogens that infect humans. Bacteria, yeast and mycobacteria, whether clinically common or rare, can cause serious harm when not identified and treated quickly. Increasingly prevalent conditions, such as sepsis or multi-drug resistant (MDR) microorganism infections, pose a serious threat to hospitals and wider public health, requiring rapid, automated microbial identification and resistance testing solutions for the entire clinical workflow.

In parallel, effective hygiene management – especially in hospitals – is key to prevent healthcare associated infections as effectively as possible.

Diagnostic solutions

Bruker’s MALDI Biotyper® system has become the method of choice for routine microorganism identification in clinical laboratories worldwide. Based on Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight mass spectrometry (MALDI-TOF MS) technology, this microbial identification system is easy-to-use, fast, robust, high-throughput, cost-effective and highly efficient. Molecular diagnostics are another rapid solution for clinical microbiology, enabling real-time results in a culture-free workflow, for example in the case of fungal infections. Bruker’s expertise in antimicrobial susceptibility testing (AST) and mycobacteria identification provides a complete solution, continuously innovating to address today’s global diseases.

molecular-diagnostics-bruker-md

Molecular Diagnostics

Molecular diagnostics significantly impacts patient care and laboratory management, with rapid real-time PCR.
505843641

Clinical Microbial Identification

Fast and accurate identification of microorganisms is the key task of microbiology. Bruker’s MALDI Biotyper® has revolutionized microbial identification.
ast-mic-resistance-testing-shutterstock-1538945498-md-web

AST / MIC / Resistance Testing

The global incidence of multi-drug resistance (MDR) among gram-negative and gram-positive pathogens has risen in recent years, with serious consequences for both hospital- and community-acquired infections.
hospital-hygiene-133610914

Hospital Hygiene

Advanced microbial strain typing, hospital hygiene and infection control solutions are improving the way hospitals deal with hospital acquired infections (HAI).
mycobacteria-shutterstock-1011747280-md-web

Mycobacteria

The mycobacteria challenge countered by fast answers with molecular diagnostics complemented by rapid and highly specific identification from culture.
fungal-infections-shutterstock-1353424817-md-web

Fungal Infections

Diagnostic tools for fast identification and susceptibility testing in fungal infections
sepsis-solution-shutterstock-130094258-md-web

Sepsis Solutions

Sepsis is the result of the body’s immune response damaging tissues and organs when attempting to fight an infection, with potentially devastating consequences. When appropriate treatment is given quickly, patients can make a full recovery, but poor recognition of symptoms and delays in identifying the causative pathogen can lead to life-changing morbidity and often mortality.
overarching-hain-shutterstock-475911697-md-web

Microbiology, Human Genetics, Virology, DNA Isolation, Instruments

With the in-vitro diagnostics Hain Lifescience product portfolio, Bruker Microbiology & Diagnostics offers comprehensive and innovation driven systems to detect a broad spectrum of pathogens and hereditary diseases.